Japan to undertake iPS cell trials in coming years

06/25/2009 | Breitbart.com

Japan reportedly is planning within five years to conduct clinical trials on induced pluripotent stem cells aimed at producing retinal pigment epithelial cells to cure age-related macular degeneration and hematopoietic stem cells to treat blood conditions, among other treatments. The plan also calls for the creation of an iPS cell bank within two years.

View Full Article in:

Breitbart.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ